Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Carisma Therapeutics, Inc. - Common Stock (NQ: CARM ) 1.000 +0.026 (+2.72%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 124,180 Open 1.000 Bid (Size) 1.000 (14) Ask (Size) 1.020 (21) Prev. Close 0.9735 Today's Range 0.9804 - 1.020 52wk Range 0.8000 - 3.418 Shares Outstanding N/A Dividend Yield 36.10% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News This NANO Nuclear Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday October 30, 2024 Via Benzinga CARM Stock Earnings: CARISMA Therapeutics Beats EPS, Beats Revenue for Q2 2024 August 08, 2024 CARM stock results show that CARISMA Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Performance YTD -64.79% -64.79% 1 Month +5.82% +5.82% 3 Month +12.36% +12.36% 6 Month -37.30% -37.30% 1 Year -67.85% -67.85% More News Read More Why Are Carisma Therapeutics Shares Surging Friday? June 28, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday June 28, 2024 Via InvestorPlace In-Depth Examination Of 5 Analyst Recommendations For CARISMA Therapeutics June 26, 2024 Via Benzinga The Analyst Verdict: CARISMA Therapeutics In The Eyes Of 4 Experts May 17, 2024 Via Benzinga The Latest Analyst Ratings for CARISMA Therapeutics October 03, 2023 Via Benzinga What 5 Analyst Ratings Have To Say About CARISMA Therapeutics September 06, 2023 Via Benzinga CARM Stock Earnings: CARISMA Therapeutics Misses EPS, Misses Revenue for Q1 2024 May 09, 2024 Via InvestorPlace CARM Stock Earnings: CARISMA Therapeutics Beats EPS, Beats Revenue for Q4 2023 April 01, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's After-Market Session January 10, 2024 Via Benzinga 3 Top Under-$5 Stocks for Strong Gains and Positive Outlook October 12, 2023 Via InvestorPlace Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 11, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 3, 2023 October 03, 2023 Via Benzinga Analyst Ratings for CARISMA Therapeutics August 11, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2023 July 06, 2023 Via Benzinga Steelcase, Commercial Metals And Other Big Stocks Moving Higher On Thursday June 22, 2023 Via Benzinga Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session June 07, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session June 07, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2023 May 24, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday May 22, 2023 Via InvestorPlace Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2023 April 14, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday March 23, 2023 Via InvestorPlace 12 Health Care Stocks Moving In Friday's Pre-Market Session March 10, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
